CTN: Net profit of 51.1775 million yuan in the first half of 2025, a year-on-year decrease of 38.76%

CTN announced that its operating revenue in the first half of 2025 was 408 million yuan, a year-on-year decrease of 36.65%. The net profit was 51.1775 million yuan, a year-on-year decrease of 38.76%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to increase capital through reserves

The concept of brain-computer interfaces has seen a surge, with Keeson hitting the daily limit up, followed by increases in VISHEE, Sanbo, CTN, Xiangyu Medical, and Innovative Medical

The brain-computer interface concept opened actively, Thalys has 4 consecutive boards

36Kr learned that as of the time of publication, the brain-computer interface concept opened actively, with Thalys achieving a 4-day consecutive limit up, and multiple stocks such as APON, Innovative Medical, NANJING PANDA, Xiangyu Medical, and CTN opening high

Zhongtai Securities: Domestic and international clinical trials reach a milestone, brain-computer interfaces accelerate from the laboratory to industrialization

Zhongtai Securities released a research report indicating that brain-computer interface (BCI) technology is accelerating from the laboratory to commercialization, with an expected global market increase of approximately $10 billion over the next decade, and the Chinese market is expected to exceed 100 billion yuan. With the advancement of clinical trials and breakthroughs in technological bottlenecks, BCI will achieve commercialization in the medical and consumer electronics fields. Non-invasive brain-computer interfaces dominate the market and are expected to achieve commercialization in the medical field within the next five years

CTN: The next-generation smart EEG headband has completed prototype development

CTN stated on the Shenzhen Stock Exchange interactive platform that its subsidiary Brain Link Technology has completed the prototype development of a new generation of smart EEG headbands. This product integrates high-precision EEG signal acquisition and intelligent analysis algorithms, suitable for scenarios such as mental health intervention, children's attention training, and cognitive training for the elderly. In terms of commercialization, the company will continue to optimize product performance and explore application scenarios in medical rehabilitation, smart elderly care, and education based on market demand